71 results
·
17ms
·
Sources: EU EUDAMED, US FDA
Filters
Classification: FDA Class 3
×
Acid, Hyaluronic, Intraarticular
FDA Pre-Market Approval
FDA Class 3
·HYALGAN
Acid, Hyaluronic, Intraarticular
FDA Pre-Market Approval
FDA Class 3
·HYALGAN
Acid, Hyaluronic, Intraarticular
FDA Pre-Market Approval
FDA Class 3
·HYALGAN(R)
Acid, Hyaluronic, Intraarticular
FDA Pre-Market Approval
FDA Class 3
·HYALGAN® (sodium hyaluronate)
Acid, Hyaluronic, Intraarticular
FDA Pre-Market Approval
FDA Class 3
·HYALGAN
Acid, Hyaluronic, Intraarticular
FDA Pre-Market Approval
FDA Class 3
·HYALGAN(R)
Acid, Hyaluronic, Intraarticular
FDA Pre-Market Approval
FDA Class 3
·HYALGAN®
Acid, Hyaluronic, Intraarticular
FDA Pre-Market Approval
FDA Class 3
·HYALGAN®
Immunohistochemistry Assay, Antibody, Programmed Death-Ligand 1
FDA Pre-Market Approval
FDA Class 3
·PD-L1 IHC 22C3 pharmDx
Immunohistochemistry Assay, Antibody, Programmed Death-Ligand 1
FDA Pre-Market Approval
FDA Class 3
·VENTANA PD-L1(SP142) Assay.
Immunohistochemistry Assay, Antibody, Programmed Death-Ligand 1
FDA Pre-Market Approval
FDA Class 3
·PD-L1 IHC 22C3 pharmDx